Sort
39,280 grants matching “leukemia”
IDENTIFICATION OF TARGETS OF BCR ABL IN THE LEUKEMOGENIC
$342,324Brandeis University · R01 · FY2001 · CA
Characterization of Erythropoiesis and Erythroid Cells.
$342,301Jeffery Miller · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2010 · DK
Posttranscriptional Regulation of Oncogene Messenger RNA
$342,283Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2003 · CA
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
$342,267Lee Ratner · Washington University · R01 · FY2024 · CA
HUMAN PLATELET IN IMMUNOHEMATOLOGIC DISEASE
$342,248University Of Pennsylvania · R01 · FY2000 · HL
V(D)J recombination, genomic instability, and cancer
$342,225New York University School Of Medicine · R01 · FY2005 · CA
V(D)J recombination, genomic instability, and cancer
$342,225New York University School Of Medicine · R01 · FY2004 · CA
Ikaros-based epigenetic regulation of T cell leukemogenesis
$342,218Katia Georgopoulos · Massachusetts General Hospital · R01 · FY2016 · CA
Ikaros-based epigenetic regulation of T cell leukemogenesis
$342,218Katia Georgopoulos · Massachusetts General Hospital · R01 · FY2015 · CA
Effect of APOBEC3G on retroviruses and retrotransposons
$342,205Bryan R. Cullen · Duke University · R01 · FY2006 · AI
Novel Strategies for Treatment of Myeloproliferative Disorders
$342,168Roya Khosravi-Far · Beth Israel Deaconess Medical Center · R01 · FY2012 · CA
Molecular and cellular analysis of G protein function
$342,168Catherine H Berlot · Geisinger Clinic · R01 · FY2010 · GM
Engineering of computational receptors and gene circuits for T-cell immunotherapy
$342,150Yvonne Yu-Hsuan Chen · University Of California Los Angeles · DP5 · FY2014 · OD
Culture Media Optimization of Support Production and Di*
$342,130Wicell Research Institute · R24 · FY2005 · RR
Pharmacological modulation of epigenetic changes in AML
$342,107Guido Marcucci · Beckman Research Institute/City Of Hope · R01 · FY2017 · CA
Pharmacological modulation of epigenetic changes in AML
$342,107Guido Marcucci · Beckman Research Institute/City Of Hope · R01 · FY2016 · CA
Mechanisms of Beta Cell Failure
$342,100Domenico Accili · Columbia University Health Sciences · R01 · FY2010 · DK
Tax regulation of HTLV-I Gene Expression through CBP
$342,072Colorado State University-Fort Collins · R01 · FY2004 · CA
Evaluation of self-inactivating lentiviral vectors for treating SCID-X1 patients
$342,062Brian P Sorrentino · St. Jude Children'S Research Hospital · P01 · FY2013 · HL
V(D)J recombination, genomic instability, and cancer
$342,057New York University School Of Medicine · R01 · FY2003 · CA
APPLYING ERROR-CORRECTED SEQUENCING TO DETECT MINIMAL RESIDUAL IN THE AAML 1031 STUDY
$342,009Todd E Druley · Washington University · R01 · FY2019 · CA
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells
$342,009Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2020 · CA
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells
$342,009Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2018 · CA
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells
$342,008Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2021 · CA
DEVELOPMENT & EVALUATION OF PRACTICABLE APPROACHES FOR GENERATION OF CYTOTOXIC &
$342,005Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2011 · CA